Rates and Clinical Characteristics of Self‐Administered Fatal Ketamine‐Related Poisoning in Australia, 2000–2025
Drug and Alcohol Review · 2026
DOI: 10.1111/dar.70058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2026. Verfasst von Shane Darke und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Drug & Alcohol Research Centre, UNSW Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Ketamine. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Drug and Alcohol Research Centre, Australian Government Department of Health, Disability and Ageing under the Drug and Alcohol Programme, Department of Health and Aged Care, Australian Government.
Abstract (Originalsprache)
Introduction
Recent years have seen marked increases in the non‐medical use of ketamine. We aimed to determine: (i) the population mortality rates of self‐administered fatal ketamine‐related poisoning cases in Australia, 2000–2022; (ii) the characteristics, toxicology and major autopsy findings of cases in Australia, 2000–2025; and (iii) changes in case characteristics across the period 2000–2025.
Methods
Retrospective study of fatal ketamine‐related poisoning in Australia retrieved from the National Coronial Information System.
Results
118 cases were identified, 100 (84.7%) of which occurred after 2014. There was a significant upward trend in event rates between 2000 and 2022 (IRR = 1.16). The mean age was 36.2 years and 77.1% were male. The majority (72.9%) of poisonings were unintentional, in 19.5% the final route of ketamine administration was by injection, and a history of substance use problems was documented in 50.8%. There were no significant differences in these case characteristics across the study period. In 14 cases, the decedent was documented as being prescribed take‐home ketamine at the time of death and had consumed this medication. The median blood ketamine concentration was 0.20 mg/L (range 0.01–25.0), which did not significantly differ across time. Psychoactive drugs other than ketamine were present in all cases, most frequently hypnosedatives (68.6%) and opioids (62.7%), with a significant difference across time observed in the presence of hypnosedatives (OR 1.45). Cardiomegaly was diagnosed in 13.9% and cardiac fibrosis in 11.1%. Discussion and Conclusions There has been a significant increase in self‐administered ketamine‐related poisoning deaths. Caution should be exercised in prescribing ketamine for self‐administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Drug & Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
- Sydney Medical School, The University of Sydney, Sydney, Australia.
- Discipline of Psychiatry and Mental Health, UNSW Sydney, Sydney, Australia.
ORCID-Profile: Shane Darke, Amy Peacock
Förderung
- National Drug and Alcohol Research Centre
- Australian Government Department of Health, Disability and Ageing under the Drug and Alcohol Programme
- Department of Health and Aged Care, Australian Government
Zitieren
APA
Darke, S., Farrell, M., Duflou, J., Lappin, J., Chrzanowska, A., & Peacock, A. (2026). Rates and Clinical Characteristics of Self‐Administered Fatal Ketamine‐Related Poisoning in Australia, 2000–2025. Drug and Alcohol Review. https://doi.org/10.1111/dar.70058
Vancouver
Darke S, Farrell M, Duflou J, Lappin J, Chrzanowska A, Peacock A. Rates and Clinical Characteristics of Self‐Administered Fatal Ketamine‐Related Poisoning in Australia, 2000–2025. Drug and Alcohol Review. 2026. doi:10.1111/dar.70058
BibTeX
@article{Darke2026,
author = {Darke, Shane and Farrell, Michael and Duflou, Johan and Lappin, Julia and Chrzanowska, Agata and Peacock, Amy},
title = {Rates and Clinical Characteristics of Self‐Administered Fatal Ketamine‐Related Poisoning in Australia, 2000–2025},
journal = {Drug and Alcohol Review},
year = {2026},
doi = {10.1111/dar.70058}
}
EUVIMED